RAIN THERAPEUTICS INC's ticker is RAIN and the CUSIP is 75082Q105. A total of 58 filers reported holding RAIN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $283,778 | -26.9% | 329,216 | +1.8% | 0.00% | – |
| Q2 2023 | $388,165 | -72.6% | 323,471 | +99.8% | 0.00% | – |
| Q1 2023 | $1,414,944 | +177211.3% | 161,893 | +62.1% | 0.00% | – |
| Q4 2022 | $798 | -99.8% | 99,860 | +34.1% | 0.00% | – |
| Q3 2022 | $363,000 | -10.6% | 74,448 | +1.8% | 0.00% | – |
| Q2 2022 | $406,000 | -59.1% | 73,141 | -62.6% | 0.00% | – |
| Q1 2022 | $992,000 | -57.4% | 195,680 | +8.3% | 0.00% | – |
| Q4 2021 | $2,327,000 | +19.7% | 180,706 | +39.1% | 0.00% | – |
| Q3 2021 | $1,944,000 | -2.0% | 129,951 | +1.7% | 0.00% | – |
| Q2 2021 | $1,984,000 | – | 127,718 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,560,652 | $7,616,000 | 1.78% |
| Cormorant Asset Management, LP | 2,326,660 | $11,354,000 | 0.79% |
| BVF INC/IL | 3,526,729 | $17,210,000 | 0.71% |
| Perceptive Advisors | 2,483,619 | $12,120,000 | 0.35% |
| Boxer Capital, LLC | 1,175,000 | $5,734,000 | 0.32% |
| UBS OCONNOR LLC | 326,451 | $1,593,000,000 | 0.03% |
| Ergoteles LLC | 65,096 | $318,000 | 0.01% |
| Lumina Fund Management LLC | 6,000 | $29,000 | 0.01% |
| Laurion Capital Management LP | 313,200 | $1,528,000 | 0.01% |
| Woodline Partners LP | 119,700 | $584,000 | 0.01% |